OTC Markets OTCQX - Delayed Quote USD

Roche Holding AG (RHHBY)

60.68 -0.62 (-1.01%)

At close: November 2 at 3:59:59 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Roche Secures FDA Clearance for New cobas eplex Respiratory Panel Detecting Up to 19 Pathogens

InvestorsHub 14h ago

ROP.SW
RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines

GlobeNewswire 14h ago

AMGN

AZN

ROP.SW
SIG vs. CFRUY: Which Stock Is the Better Value Option?

Zacks 15h ago

SIG

CFRHF
Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption

GlobeNewswire 15h ago

TMO

ROP.SW

DHR
Roche receives FDA 510(k) clearance for new cobas® eplex respiratory pathogen panel 3, enabling labs to customize respiratory testing for local patient needs

PR Newswire 16h ago

RHHBF

RO

ROP
UBS sees Roche giredestrant potential priced in after 50% share rally

Investing.com 19h ago

ROP.SW

ROPC

RO.SW
FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight

Stocktwits 20h ago

ROP.SW

ALNY

REGN
Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial

Simply Wall St. 1d ago

NVS

ROP.SW

NOVN
Roche Holding (SWX:ROP) Expands ADC Pipeline As Late Stage Trial Results Impress

Simply Wall St. 1d ago

ROP.SW

3692.HK

ROP
Roche, In A Buy Zone, Leans On Diagnostics To Overcome Light Drug Sales

Investor's Business Daily 11d ago

ROP.SW

RHHBY
-1.01%
Roche Drops as Phase 3 Kidney Signal Needs Two-Year Proof

GuruFocus.com 1mo ago

ROP.SW

NVS

RHHBY
-1.01%
EXEL Q3 Earnings Beat Estimates on Strong Cabometyx Sales

Zacks 3d ago

EXEL

RHHBF

MRK

Performance Overview

Return	RHHBY	MSCI WORLD (^990100-USD-STRD)
YTD	+21.15%	+8.64%
1-Year	+54.95%	+10.32%
3-Year	+105.13%	+73.14%

U.S. markets open in 7h 41m

Roche Holding AG (RHHBY)

Roche Secures FDA Clearance for New cobas eplex Respiratory Panel Detecting Up to 19 Pathogens

RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines

SIG vs. CFRUY: Which Stock Is the Better Value Option?

Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption

Roche receives FDA 510(k) clearance for new cobas® eplex respiratory pathogen panel 3, enabling labs to customize respiratory testing for local patient needs

UBS sees Roche giredestrant potential priced in after 50% share rally

FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight

Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial

Roche Holding (SWX:ROP) Expands ADC Pipeline As Late Stage Trial Results Impress

Roche, In A Buy Zone, Leans On Diagnostics To Overcome Light Drug Sales

Roche Drops as Phase 3 Kidney Signal Needs Two-Year Proof

EXEL Q3 Earnings Beat Estimates on Strong Cabometyx Sales